{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T05:50:56Z","timestamp":1783749056875,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36200-2","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:27:18Z","timestamp":1770348438000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of iron chelation therapy on thyroid function in beta-thalassemia major patients from Pakistan"],"prefix":"10.1038","volume":"16","author":[{"given":"Arsalan Waqas Ahmad","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulaiman","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Jaseem","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Jawad","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawad","family":"Inayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"8","key":"36200_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMra2021838","volume":"384","author":"AT Taher","year":"2021","unstructured":"Taher, A. T., Musallam, K. M. & Cappellini, M. D. \u03b2-Thalassemias. N. Engl. J. Med. 384(8), 727\u2013743 (2021).","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"36200_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000732","volume":"6","author":"D Farmakis","year":"2022","unstructured":"Farmakis, D. et al. 2021 Thalassaemia International Federation guidelines for the management of transfusion-dependent thalassemia. Hemasphere. 6(8), e732 (2022).","journal-title":"Hemasphere."},{"issue":"22","key":"36200_CR3","doi-asserted-by":"publisher","first-page":"16263","DOI":"10.3390\/ijms242216263","volume":"24","author":"P Evangelidis","year":"2023","unstructured":"Evangelidis, P., Venou, T.-M., Fani, B., Vlachaki, E. & Gavriilaki, E. Endocrinopathies in hemoglobinopathies: what is the role of iron?. Int. J. Mol. Sci. 24(22), 16263 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"36200_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/03630269.2021.2003382","volume":"45","author":"S Haghpanah","year":"2021","unstructured":"Haghpanah, S. et al. The prevalence of hypothyroidism among patients with \u03b2-thalassemia: a systematic review and meta-analysis of cross-sectional studies. Hemoglobin 45(5), 275\u2013286 (2021).","journal-title":"Hemoglobin"},{"issue":"2","key":"36200_CR5","first-page":"98","volume":"20","author":"A Sohal","year":"2024","unstructured":"Sohal, A. & Kowdley, K. V. A review of new concepts in iron overload. Gastroenterology & Hepatology. 20(2), 98 (2024).","journal-title":"Gastroenterology & Hepatology."},{"key":"36200_CR6","unstructured":"Ullah S, Ayub M, Khan N, Tariq I, Inayat F. Role of Fine-Needle Aspiration Cytology (FNAC) and Its Limitations in the Preoperative Diagnosis of Thyroid Cancer. The Sciencetech. 2023;4(2)."},{"key":"36200_CR7","doi-asserted-by":"crossref","unstructured":"Savvidis C, Ilias I. Endocrine dysfunction in homozygous beta-thalassemia: An underrecognized and undertreated consequence of prolonged survival. World Journal of Clinical Cases. 2025;13(24).","DOI":"10.12998\/wjcc.v13.i24.107612"},{"key":"36200_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115649","volume":"143","author":"V Ekbote","year":"2021","unstructured":"Ekbote, V. et al. Increased prevalence of fractures in inadequately transfused and chelated Indian children and young adults with beta thalassemia major. Bone 143, 115649 (2021).","journal-title":"Bone"},{"issue":"2","key":"36200_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077342","volume":"14","author":"A Premawardhena","year":"2024","unstructured":"Premawardhena, A. et al. Efficacy and safety of deferoxamine, deferasirox and deferiprone triple iron chelator combination therapy for transfusion-dependent \u03b2-thalassaemia with very high iron overload: a protocol for randomised controlled clinical trial. BMJ Open 14(2), e077342 (2024).","journal-title":"BMJ Open"},{"issue":"3","key":"36200_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/acsbiomedchemau.3c00066","volume":"4","author":"N Marupudi","year":"2024","unstructured":"Marupudi, N. & Xiong, M. P. Genetic targets and applications of iron chelators for neurodegeneration with brain iron accumulation. ACS Bio & Med Chem Au. 4(3), 119\u2013130 (2024).","journal-title":"ACS Bio & Med Chem Au."},{"key":"36200_CR11","doi-asserted-by":"crossref","unstructured":"Iram K, Ali Z, Aamer F, Shiekh A, Hassan M. Comparison of Deferasirox and Desferrioxamine in Term of Mean Serum Ferritin Levels in Patients of \u03b2-Thalassemia Major with Iron Overload: Effect of Deferasirox and Desferrioxamine in \u03b2-Thalassemia Major. Pakistan Journal of Health Sciences. 2024:13\u20136.","DOI":"10.54393\/pjhs.v5i08.1519"},{"issue":"1","key":"36200_CR12","doi-asserted-by":"publisher","first-page":"725","DOI":"10.71000\/1wm8nt06","volume":"3","author":"F Anwar","year":"2025","unstructured":"Anwar, F. et al. Frequency of hypothyroidism in beta thalassemia major children. Insights-J. Health and Rehabilitation. 3(1), 725\u2013731 (2025).","journal-title":"Insights-J. Health and Rehabilitation."},{"issue":"1","key":"36200_CR13","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12944-025-02740-1","volume":"24","author":"F Inayat","year":"2025","unstructured":"Inayat, F., Shams, S., Ullah, N., Ahmad Shah, A. W. & Haq, I. U. Exploring the associations of the triglyceride-glucose index with thyroid function in subclinical hypothyroid patients: a cross-sectional study. Lipids Health Dis. 24(1), 337 (2025).","journal-title":"Lipids Health Dis."},{"issue":"2","key":"36200_CR14","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4103\/trp.trp_4_20","volume":"17","author":"A Singhal","year":"2020","unstructured":"Singhal, A. & Goyal, H. Thyroid dysfunction in beta thalassemia major patients. Thyroid Res. Practice. 17(2), 70\u201375 (2020).","journal-title":"Thyroid Res. Practice."},{"issue":"2","key":"36200_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3324\/haematol.2020.272419","volume":"107","author":"M Casale","year":"2021","unstructured":"Casale, M. et al. Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: A risk assessment study from a multi-center nation-wide cohort. Haematologica 107(2), 467 (2021).","journal-title":"Haematologica"},{"issue":"1","key":"36200_CR16","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3329\/bjms.v20i1.50357","volume":"20","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S. & Chakrabarti, D. Estimation of serum ferritin and TSH levels in thalassemia patients undergoing iron chelation therapy. Bangladesh J. Med. Sci. 20(1), 130\u2013135 (2021).","journal-title":"Bangladesh J. Med. Sci."},{"issue":"3","key":"36200_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.12669\/pjms.39.3.6837","volume":"39","author":"SE Malik","year":"2023","unstructured":"Malik, S. E. et al. Endocrine disorders in Beta-Thalassemia major patients at a Tertiary Care Hospital. Pak J. Med. Sci. 39(3), 726\u2013731 (2023).","journal-title":"Pak J. Med. Sci."},{"issue":"7","key":"36200_CR18","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.19082\/2620","volume":"8","author":"ZT Asad","year":"2016","unstructured":"Asad, Z. T., Ghazanfari, M., Naleini, S. N., Sabagh, A. & Kooti, W. Evaluation of serum levels in T3, T4 and TSH in beta-thalassemic patients referred to the Abuzar hospital in Ahwaz. Electron Physician. 8(7), 2620\u20132624 (2016).","journal-title":"Electron Physician."},{"key":"36200_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/105072502753522383","volume":"12","author":"A Zervas","year":"2002","unstructured":"Zervas, A. et al. Assessment of Thyroid Function in Two Hundred Patients with \u03b2 -Thalassemia Major. Thyroid\u202f: official J. Am. Thyroid Association. 12, 151\u2013154 (2002).","journal-title":"Thyroid : official J. Am. Thyroid Association."},{"key":"36200_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.3329\/bjms.v20i1.50357","volume":"20","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S. & Chakrabarti, D. Estimation of serum ferritin and TSH levels in thalassemia patients undergoing iron chelation therapy. Bangladesh J. Med. Sci. 20, 130\u2013135 (2021).","journal-title":"Bangladesh J. Med. Sci."},{"issue":"2","key":"36200_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3324\/haematol.2020.272419","volume":"107","author":"M Casale","year":"2022","unstructured":"Casale, M. et al. Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort. Haematologica 107(2), 467\u2013477 (2022).","journal-title":"Haematologica"},{"key":"36200_CR22","doi-asserted-by":"crossref","unstructured":"Casale M, Forni GL, Cassinerio E, Origa R, Serra M, Campisi S, et al. Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort. Haematologica. 2021;107.","DOI":"10.3324\/haematol.2020.272419"},{"issue":"1","key":"36200_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/0973-6247.200768","volume":"11","author":"HM Al-Kuraishy","year":"2017","unstructured":"Al-Kuraishy, H. M. & Al-Gareeb, A. I. Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent \u03b2-thalassemia. Asian J Transfus Sci. 11(1), 13\u201317 (2017).","journal-title":"Asian J Transfus Sci."},{"issue":"3","key":"36200_CR24","first-page":"159","volume":"8","author":"S Ansari","year":"2017","unstructured":"Ansari, S., Azarkeivan, A., Miri-Aliabad, G., Yousefian, S. & Rostami, T. Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior. Caspian J. Intern. Med. 8(3), 159\u2013164 (2017).","journal-title":"Caspian J. Intern. Med."},{"issue":"1","key":"36200_CR25","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/07853890.2022.2028894","volume":"54","author":"PS Reddy","year":"2022","unstructured":"Reddy, P. S., Locke, M. & Badawy, S. M. A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia. Ann Med. 54(1), 326\u2013342 (2022).","journal-title":"Ann Med."},{"key":"36200_CR26","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/07853890.2022.2028894","volume":"54","author":"P Reddy","year":"2022","unstructured":"Reddy, P., Locke, M. & Badawy, S. A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia. Ann. Med. 54, 326\u2013342 (2022).","journal-title":"Ann. Med."},{"issue":"1","key":"36200_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/thalassrep15010002","volume":"15","author":"S Deumi\u0107","year":"2025","unstructured":"Deumi\u0107, S., Crn\u010devi\u0107, N., Huki\u0107, M., Dizdar, M. & Avdi\u0107, M. New Perspectives on the Impact of Iron Chelation Therapy on the Gut Microbiome in Thalassemia Patients. Thalassemia Reports. 15(1), 2 (2025).","journal-title":"Thalassemia Reports."},{"issue":"2","key":"36200_CR28","doi-asserted-by":"publisher","first-page":"160","DOI":"10.61336\/appj\/22-2-34","volume":"22","author":"AMT Al Mosawi","year":"2023","unstructured":"Al Mosawi, A. M. T. & Kadhim, H. M. Comparison of Deferasirox (Exjade R) and Deferoxamine (Desferal R) Effects on Iron Overload in Patients with Blood Transfusion-Dependent \u03b2-Thalassemia Major in Iraq. Azerbaijan Pharmaceutical and Pharmacotherapy J. 22(2), 160\u2013163 (2023).","journal-title":"Azerbaijan Pharmaceutical and Pharmacotherapy J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36200-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36200-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36200-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:08:05Z","timestamp":1771978085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36200-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36200"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36200-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethical Committee of the Iqra National University, Peshawar, Pakistan, (Ref: INU\/AHS\/131\u201323). Written informed consent was obtained from all participants or their legal guardians (for minors) prior to enrollment. All procedures were conducted in accordance with the Declaration of Helsinki (2013 revision).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable (manuscript contains no individual personal data).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"7533"}}